Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 1
1985 1
1987 1
1988 1
1989 1
1990 1
1992 1
1993 1
1995 1
1996 3
1999 4
2001 4
2002 4
2003 4
2004 4
2005 7
2006 5
2007 10
2008 5
2009 9
2010 9
2011 9
2012 2
2013 8
2014 5
2015 8
2016 7
2017 5
2018 6
2019 8
2020 6
2021 5
2022 4
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Estrogen resistance syndrome"
Page 1
Preventing urinary tract infections after menopause without antibiotics.
Caretto M, Giannini A, Russo E, Simoncini T. Caretto M, et al. Maturitas. 2017 May;99:43-46. doi: 10.1016/j.maturitas.2017.02.004. Epub 2017 Feb 7. Maturitas. 2017. PMID: 28364867 Review.
Evidence shows that topical estrogens normalize vaginal flora and greatly reduce the risk of UTIs. The use of intravaginal estrogens may be reasonable in postmenopausal women not taking oral estrogens. ...
Evidence shows that topical estrogens normalize vaginal flora and greatly reduce the risk of UTIs. The use of intravaginal estroge …
Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2/HO-1/Cyp1b1 pathway: Integrating network pharmacology and experimental validation in vivo.
Zheng R, Shen H, Li J, Zhao J, Lu L, Hu M, Lin Z, Ma H, Tan H, Hu M, Li J. Zheng R, et al. J Ethnopharmacol. 2023 Jan 30;301:115824. doi: 10.1016/j.jep.2022.115824. Epub 2022 Oct 20. J Ethnopharmacol. 2023. PMID: 36273747
This study was designed to identify its chemical and pharmacological properties. MATERIALS AND METHODS: Network pharmacology was used to predict the active compounds, potential targets, and pathways of QGW. Female C57BL/6J mice were injected with letrozole and fed a high-f …
This study was designed to identify its chemical and pharmacological properties. MATERIALS AND METHODS: Network pharmacology was used to …
Dyslipidemia in PCOS.
Wild RA. Wild RA. Steroids. 2012 Mar 10;77(4):295-9. doi: 10.1016/j.steroids.2011.12.002. Epub 2011 Dec 14. Steroids. 2012. PMID: 22197663 Review.
Life-long apolipoprotein lipid metabolic dysfunction in women with PCOS exaggerates the risk for cardiovascular disease (CVD) with aging. The dysfunction has involved insulin resistance (IR), which occurs in most women with PCOS. Women with PCOS have androgen excess, IR, v …
Life-long apolipoprotein lipid metabolic dysfunction in women with PCOS exaggerates the risk for cardiovascular disease (CVD) with aging. Th …
Sex steroids and glucose metabolism.
Allan CA. Allan CA. Asian J Androl. 2014 Mar-Apr;16(2):232-8. doi: 10.4103/1008-682X.122589. Asian J Androl. 2014. PMID: 24457840 Free PMC article. Review.
Testosterone levels are lower in men with metabolic syndrome and type 2 diabetes mellitus (T2DM) and also predict the onset of these adverse metabolic states. ...Sex hormone binding globulin is also inversely associated with insulin resistance and T2DM but th …
Testosterone levels are lower in men with metabolic syndrome and type 2 diabetes mellitus (T2DM) and also predict the onset of …
Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk.
Pandurevic S, Macut D, Fanelli F, Pagotto U, Gambineri A. Pandurevic S, et al. Biomolecules. 2021 Sep 12;11(9):1350. doi: 10.3390/biom11091350. Biomolecules. 2021. PMID: 34572562 Free PMC article. Review.
The variability of the syndrome's phenotype is derived from the genetic and molecular heterogeneity, with a great deal of environmental factors that may have long-term health consequences, such as metabolic and cardiovascular (CV) diseases. ...Obesity, low steroid h …
The variability of the syndrome's phenotype is derived from the genetic and molecular heterogeneity, with a great deal of envi …
Sex hormone-binding globulin and polycystic ovary syndrome.
Zhu JL, Chen Z, Feng WJ, Long SL, Mo ZC. Zhu JL, et al. Clin Chim Acta. 2019 Dec;499:142-148. doi: 10.1016/j.cca.2019.09.010. Epub 2019 Sep 13. Clin Chim Acta. 2019. PMID: 31525346 Review.
Low serum SHBG levels are considered a biomarker of abnormal metabolism and are related to insulin resistance (IR), compensatory hyperinsulinemia and abnormalities in glucose and lipid metabolism in PCOS patients. SHBG is also associated with the long-term prognosis …
Low serum SHBG levels are considered a biomarker of abnormal metabolism and are related to insulin resistance (IR), compensatory hype …
Cardiovascular Risk in Perimenopausal Women.
Stevenson JC, Tsiligiannis S, Panay N. Stevenson JC, et al. Curr Vasc Pharmacol. 2019;17(6):591-594. doi: 10.2174/1570161116666181002145340. Curr Vasc Pharmacol. 2019. PMID: 30280667 Review.
There is a reduction in insulin secretion and elimination, but increases in insulin resistance eventually result in increasing circulating insulin levels. ...There is an increase in the incidence of hypertension and of type 2 diabetes mellitus, both major risk factors for …
There is a reduction in insulin secretion and elimination, but increases in insulin resistance eventually result in increasing circul …
Oral contraceptives in polycystic ovary syndrome.
Helvaci N, Yildiz BO. Helvaci N, et al. Minerva Endocrinol. 2014 Sep;39(3):175-87. Epub 2014 Jul 8. Minerva Endocrinol. 2014. PMID: 25003228 Review.
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of reproductive age and combined oral contraceptives (OCs) are often the first-line treatment of the syndrome by improving hyperandrogenism and regulating menstrual cycles. Oral contrace …
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of reproductive age and combined oral contraceptives …
Polycystic ovarian syndrome--prognosis and treatment outcomes.
Hart R. Hart R. Curr Opin Obstet Gynecol. 2007 Dec;19(6):529-35. doi: 10.1097/GCO.0b013e3282f10e22. Curr Opin Obstet Gynecol. 2007. PMID: 18007129 Review.
PURPOSE OF REVIEW: Polycystic ovarian syndrome is the commonest endocrine disorder of reproductive-age women. ...This review provides an update of recent findings for the management of polycystic ovarian syndrome. RECENT FINDINGS: Studies have been performed to dete …
PURPOSE OF REVIEW: Polycystic ovarian syndrome is the commonest endocrine disorder of reproductive-age women. ...This review provides …
Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women.
Rose DP, Haffner SM, Baillargeon J. Rose DP, et al. Endocr Rev. 2007 Dec;28(7):763-77. doi: 10.1210/er.2006-0019. Epub 2007 Nov 2. Endocr Rev. 2007. PMID: 17981890 Review.
Type 2 diabetes and the metabolic syndrome, which are more common in AA women, have also been associated with breast cancer risk. ...This review explores the specific roles of obesity, body fat distribution (particularly visceral and sc adipose tissue), type 2 diabetes, me …
Type 2 diabetes and the metabolic syndrome, which are more common in AA women, have also been associated with breast cancer risk. ... …
138 results